# Impact of Inflammation Biomarkers on the Acute Respiratory Distress Syndrome (ARDS) Definition

> **NCT01161901** · — · COMPLETED · sponsor: **University Hospital, Clermont-Ferrand** · enrollment: 134 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **PROCEDURE:** blood sample

## Key facts

- **NCT ID:** NCT01161901
- **Lead sponsor:** University Hospital, Clermont-Ferrand
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01161901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01161901, "Impact of Inflammation Biomarkers on the Acute Respiratory Distress Syndrome (ARDS) Definition". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01161901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*